Dyne Therapeutics (DYN) Other financing activities (2025 - 2026)
Dyne Therapeutics (DYN) recorded quarterly Other financing activities of $30000.0 in Q1 2026, down 48.28% quarter-over-quarter from $58000.0 in Q4 2025.
Dyne Therapeutics (DYN) Other financing activities (2025 - 2026) Analysis & Trends
Dyne Therapeutics' Other financing activities history runs 2 years deep, the most recent figure standing at $30000.0 for Q1 2026.
- In Q1 2026, Other financing activities changed N/A year-over-year to $30000.0; the TTM figure through Mar 2026 stood at $88000.0 (changed N/A YoY), while the FY2025 annual figure was $558000.0, changed N/A from the prior year.
- Other financing activities was $30000.0 for Q1 2026 at Dyne Therapeutics, down from $58000.0 in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $58000.0 in Q4 2025 to a low of $30000.0 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - |
| 10 | Dyne Therapeutics | 3.00 Bn | 3.00 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 30,000.00 |
| Mar 31, 2026 | 30,000.00 |
| Dec 31, 2025 | 58,000.00 |
| Dec 31, 2025 | 58,000.00 |